Ipek Yonal-Hindilerden

Istanbul, 34093, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations-A Single-Center Study from Turkey.

IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations-A Single-Center Study from Turkey.

Journal: Current issues in molecular biology

Published: July 05, 2026

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Journal: Journal of thrombosis and thrombolysis

Published: April 14, 2026

Emerging Survival Predictor Model in Essential Thrombocythemia: The AAA+ Model.

Emerging Survival Predictor Model in Essential Thrombocythemia: The AAA+ Model.

Journal: American journal of hematology

Published: October 17, 2025

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.

Journal: Turkish journal of medical sciences

Published: August 26, 2025

Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications.

Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications.

Journal: Transplant immunology

Published: August 19, 2025

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond.

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond.

Journal: Blood advances

Published: July 30, 2025

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond.

A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond.

Journal: Blood advances

Published: July 30, 2025

A Practical Tool for Predicting Outcomes in Essential Thrombocythemia: Triple A Risk Model and Beyond.

A Practical Tool for Predicting Outcomes in Essential Thrombocythemia: Triple A Risk Model and Beyond.

Journal: Blood advances

Published: July 30, 2025

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Journal: Bone marrow transplantation

Published: July 24, 2025

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Journal: Bone marrow transplantation

Published: July 01, 2025

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: August 08, 2024

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: August 16, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026